SYNTAB THERAPEUTICS
Syntab Therapeutics is a German biotech company that has developed an immuno-oncology therapy which employs the innate immune system to kill cancer cells highly effectively and to provide long-lasting anti-cancer benefits to patients. Syntab’s technology platform offers a new path in the cancer therapy space and is expected to exhibit excellent selectivity for a range of cancer-relevant targets. The company established a lean management for its development in tight collaboration with a few selective and excellent academic partners as the group of Prof. Christian Becker in Vienna and Aachen University for preclinical studies. The company has its registered office in Würselen close to Aachen.
SYNTAB THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Oncology Therapeutics
Founded:
2010-01-01
Address:
Würselen, Nordrhein-Westfalen, Germany
Country:
Germany
Website Url:
http://www.syntab-therapeutics.com
Status:
Active
Contact:
+49 (0) 2405 40 999 50
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Domain Not Resolving SSL By Default Apple Mobile Web Clips Icon Apache Microsoft Azure DNS DigiCert SSL IONOS
Similar Organizations
Xilio Therapeutics
Xilio Therapeutics is a biopharmaceutical company focused on developing highly-potent, targeted immuno-oncology therapeutics.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Beren Therapeutics
Beren Therapeutics is a biotechnology company that develops innovative therapies to make them accessible to every patient.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Mosaic Biomedicals
Mosaic Biomedicals was a Catalan biotechnology company developing humanised antibodies for the use in oncology.
NBE-Therapeutics
NBE-Therapeutics is a biotech company that develops oncology treatments for cancer patients.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Seven and Eight Biopharmaceuticals
Seven and Eight Biopharmaceuticals is a biopharmaceutical company that develops proprietary novel immuno-oncology therapies.
Official Site Inspections
http://www.syntab-therapeutics.com
- Host name: 217-160-0-29.elastic-ssl.ui-r.com
- IP address: 217.160.0.29
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Syntab Therapeutics"
Syntab Therapeutics - Innovative Immuno-oncology Therapy
That’s what Syntab Therapeutics makes use of: The activation of the first line of immune defense, the innate immune system in order to fight cancer cells. Syntab Therapeutics‘ novel and …See details»
Syntab Therapeutics - Crunchbase Company Profile
Syntab Therapeutics is a German biotech company that has developed an immuno-oncology therapy which employs the innate immune system to kill …See details»
Syntab Therapeutics - Drug pipelines, Patents, Clinical trials
May 7, 2025 Explore Syntab Therapeutics with its drug pipeline, therapeutic area, technology platform, 1 literature, Disease Domain:Neoplasms, Technology Platform:Antibody drug …See details»
Syntab Therapeutics Company Profile - Office Locations ... - Craft
Syntab Therapeutics is a biotech company developing immuno-oncology therapy that employs the innate immune system to kill cancer cells. It has a pipeline of different immuno-oncology drug …See details»
Syntab Therapeutics - Overview, News & Similar companies
Who is Syntab Therapeutics. Founded in October 2010, Syntab Therapeutics is committed to the exploration and development of innovative drugs against severe diseases such as ca ncer. In …See details»
Syntab Therapeutics GmbH Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Syntab Therapeutics GmbH of Würselen, Nordrhein-Westfalen. Get the latest business insights from …See details»
Syntab Therapeutics GmbH Name - medlife-ev.com
Syntab Therapeutics GmbH St. Jobser Straße 56 52146 Würselen · Germany Ute Steinbusch +49 2405 40999 50 [email protected] www.syntab-therapeutics.com 2010 Name …See details»
Management Team - Syntab Therapeutics
Dipl.-Biol. Ute Steinbusch MBA has been the managing director of Syntab Therapeutics since 2012. She joined the company in 2011. Formerly, she was head of marketing and business …See details»
Syntab Therapeutics GmbH | MedLife
Syntab Therapeutics is a German biotech company that develops an immuno-oncology therapy which employs the innate immune system to kill cancer cells highly effectively and to provide …See details»
Syntab Therapeutics - Aachen, Deutschland - bionity.com
Die im Oktober 2010 gegründete Syntab Therapeutics erforscht und entwickelt innovative Wirkstoffe mithilfe der firmeneigenen Plattform zur Herstellung synthetischer Antikörper. …See details»
History - Syntab Therapeutics
Syntab Therapeutics has been supported by public funding from the German Ministry of Education and Research (BMBF), later on by the State Northrhine-Westphalia and its EFRE …See details»
Syntab Therapeutics GmbH: Drug pipelines, Patents, Clinical trials ...
Explore Syntab Therapeutics GmbH with its drug pipeline, therapeutic area, technology platform, 1 literature, Disease Domain:Neoplasms, Technology Platform:Monoclonal antibody, Antibody …See details»
Innovative Immuno-oncology Therapy - Syntab Therapeutics
Syntab Therapeutics is a German biotech company that has developed an immuno-oncology therapy which employs the innate immune system to kill cancer cells highly effectively and to …See details»
Antibody-drug Conjugate Information | ADCdb
Organization: Syntab Therapeutics GmbH. Drug Status: Investigative. Indication: In total 1 Indication(s) Solid tumors [ICD11:2A00-2A0Z|2B50-2F9Z] Investigative. 3D MOL. 2D MOL. …See details»
NovoKolon - ZukunftBio.NRW
Die Syntab Therapeutics GmbH am Standort Würselen bei Aachen erforscht und entwickelt innovative Wirkstoffe mithilfe der firmeneigenen Plattform zur Herstellung synthetischer …See details»
Technology - syntab therapeutics
This completely new approach was proven by several in-vitro and in-vivo studies in different animal and tumor models. Combining the specific binding to tumor surface markers with …See details»
SAB-Y27 - Drug Targets, Indications, Patents - Synapse - Patsnap
May 7, 2025 Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.See details»
View Interesting News and Updates - Syntab Therapeutics
Oct 14, 2016 Syntab Therapeutics is the leading partner of a novel initiative called MammaExplant. Funded by the Federal Ministry of Education and Research …See details»
SAB-Y14 - Drug Targets, Indications, Patents - Synapse
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.See details»
Products - Syntab Therapeutics
Syntab Therapeutics has established a pipeline of different immuno-oncology drug candidates with bi- or multispecific properties of which the pilot candidate has already shown promising …See details»